127 related articles for article (PubMed ID: 23456380)
1. Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma.
Arrese D; McNally ME; Chokshi R; Feria-Arias E; Schmidt C; Klemanski D; Gregory G; Khabiri H; Shah M; Bloomston M
Ann Surg Oncol; 2013 Apr; 20(4):1114-20. PubMed ID: 23456380
[TBL] [Abstract][Full Text] [Related]
2. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review.
Shirley LA; McNally M; Chokshi R; Jones N; Tassone P; Guy G; Khabiri H; Schmidt C; Shah M; Bloomston M
World J Surg Oncol; 2015 May; 13():167. PubMed ID: 25927667
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.
McNally ME; Martinez A; Khabiri H; Guy G; Michaels AJ; Hanje J; Kirkpatrick R; Bloomston M; Schmidt CR
Ann Surg Oncol; 2013 Mar; 20(3):923-8. PubMed ID: 22965570
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
6. The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization.
Yau T; Yao TJ; Chan P; Epstein RJ; Ng KK; Chok SH; Cheung TT; Fan ST; Poon RT
Cancer; 2009 Dec; 115(23):5507-15. PubMed ID: 19701904
[TBL] [Abstract][Full Text] [Related]
7. Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis.
Seehofer D; Nebrig M; Denecke T; Kroencke T; Weichert W; Stockmann M; Somasundaram R; Schott E; Puhl G; Neuhaus P
Clin Transplant; 2012; 26(5):764-74. PubMed ID: 22432589
[TBL] [Abstract][Full Text] [Related]
8. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
[TBL] [Abstract][Full Text] [Related]
9. Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
Kitano M; Davidson GW; Shirley LA; Schmidt CR; Guy GE; Khabiri H; Dowell JD; Shah MH; Bloomston M
Ann Surg Oncol; 2016 Nov; 23(12):4008-4015. PubMed ID: 27393568
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.
Park CH; Chung JW; Jang SJ; Chung MJ; Bang S; Park SW; Song SY; Chung JB; Park JY
J Gastroenterol Hepatol; 2012 Aug; 27(8):1306-11. PubMed ID: 22414232
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
[TBL] [Abstract][Full Text] [Related]
12. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
13. Chemoembolization in patients at high risk: results and complications.
Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
[TBL] [Abstract][Full Text] [Related]
16. Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma.
Kim HY; Park JW; Joo J; Jung SJ; An S; Woo SM; Kim HB; Koh YH; Lee WJ; Kim CM
J Gastroenterol Hepatol; 2012 Jun; 27(6):1051-6. PubMed ID: 22098152
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
Bloomston M; Binitie O; Fraiji E; Murr M; Zervos E; Goldin S; Kudryk B; Zwiebel B; Black T; Fargher S; Rosemurgy AS
Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160
[TBL] [Abstract][Full Text] [Related]
18. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine hepatic metastases: does aggressive management improve survival?
Touzios JG; Kiely JM; Pitt SC; Rilling WS; Quebbeman EJ; Wilson SD; Pitt HA
Ann Surg; 2005 May; 241(5):776-83; discussion 783-5. PubMed ID: 15849513
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
